[Cyclophosphamide pulse therapy of systemic lupus erythematosus with renal involvement].
Study design and preliminary data of a prospective randomized trial with monthly administration of intravenous cyclophosphamide in so far 12 patients with systemic lupus erythematosus (SLE) and nephritis are presented.
Hein
R
R
Abteilung Immunologie und Transfusionsmedizin, Medizinische Hochschule Hannover.
Neumann
K H
KH
Koch
K M
KM
Deicher
H
H
Schmidt
R E
RE
D000328:Adult; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008181:Lupus Nephritis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies
D003520:Cyclophosphamide
Cyclophosphamid-Stosstherapie des systemischen Lupus erythematodes mit Nierenbeteiligung.